Virpax Pharmaceuticals (VRPX) Stock Chart & Stock Price History → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free VRPX Stock Alerts $0.78 -0.02 (-2.50%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Virpax Pharmaceuticals Stock Price Performance5 Day Performance-65.90%1 Month Performance-78.37%3 Month Performance-76.40%6 Month Performance-88.84%Year-To-Date Performance-75.60%1 Year Performance-90.70% Receive VRPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit VRPX Stock Chart for Sunday, May, 19, 2024 VRPX Chart by TradingView Virpax Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$0.79$0.78-1.26%$0.82$0.77265,902 shs$914,000.0005/16/2024$0.78$0.79+1.41%$0.81$0.75492,990 shs$926,000.0005/15/2024$2.29$0.78-65.94%$0.92$0.682.70 million shs$913,000.0005/14/2024$3.04$2.29-24.67%$2.82$1.98125,134 shs$2.68 million05/13/2024$2.55$3.04+19.22%$3.14$2.5541,573 shs$3.56 million05/10/2024$2.49$2.55+2.41%$2.61$2.456,243 shs$2.98 million Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.36$2.49+5.51%$2.66$2.3025,088 shs$2.91 million05/08/2024$2.16$2.36+9.26%$2.49$2.2012,981 shs$2.76 million05/07/2024$2.31$2.16-6.49%$2.50$2.156,852 shs$2.53 million05/06/2024$2.24$2.31+3.12%$2.31$2.202,455 shs$2.71 million05/03/2024$2.23$2.24+0.45%$2.66$2.247,425 shs$2.62 million05/02/2024$2.54$2.23-12.20%$2.50$2.1140,171 shs$2.61 million05/01/2024$2.71$2.54-6.27%$2.78$2.5040,898 shs$2.97 million04/30/2024$2.75$2.71-1.45%$2.92$2.5118,086 shs$3.17 million04/29/2024$3.10$2.75-11.29%$3.00$2.7519,504 shs$3.22 million04/26/2024$2.87$3.10+8.01%$3.28$3.075,246 shs$3.63 million04/25/2024$3.09$2.87-7.12%$3.06$2.868,337 shs$3.36 million04/24/2024$3.16$3.09-2.22%$3.37$3.074,656 shs$3.62 million04/23/2024$3.32$3.16-4.82%$3.30$3.0011,455 shs$3.70 million04/22/2024$3.68$3.32-9.79%$3.65$3.2316,065 shs$3.89 million04/19/2024$3.91$3.61-7.67%$3.95$3.615,952 shs$4.22 million04/18/2024$3.47$3.91+12.68%$3.91$3.3120,060 shs$4.58 million04/17/2024$3.47$3.47$3.47$3.301,922 shs$4.06 million04/16/2024$3.53$3.47-1.71%$3.47$3.282,753 shs$4.06 million04/15/2024$3.55$3.53-0.55%$3.53$3.301,498 shs$4.13 million04/12/2024$3.61$3.55-1.66%$3.55$3.259,177 shs$4.15 million04/11/2024$3.66$3.61-1.37%$3.62$3.611,020 shs$4.22 million04/10/2024$3.51$3.66+4.27%$3.70$3.511,983 shs$4.28 million04/09/2024$3.72$3.51-5.65%$3.65$3.347,381 shs$4.11 million04/08/2024$3.89$3.72-4.37%$4.05$3.4526,846 shs$4.36 million04/05/2024$4.09$3.89-4.89%$3.96$3.6116,955 shs$4.55 million04/04/2024$4.16$4.09-1.68%$4.17$3.991,554 shs$4.79 million04/03/2024$4.17$4.16-0.24%$4.24$4.073,428 shs$4.87 million04/02/2024$4.21$4.17-0.95%$4.24$4.007,667 shs$4.88 million04/01/2024$4.26$4.21-1.20%$4.27$3.979,687 shs$4.93 million03/29/2024$4.14$4.26+2.93%$4.26$3.7215,504 shs$4.99 million03/28/2024$3.77$4.14+9.81%$4.26$3.7215,504 shs$4.85 million03/27/2024$3.88$3.77-2.84%$3.97$3.487,669 shs$4.41 million03/26/2024$3.74$3.88+3.74%$3.90$3.6914,431 shs$4.54 million03/25/2024$4.03$3.74-7.20%$3.99$3.705,409 shs$4.38 millionweirdest stock market marches on (Ad)For the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth. And he sure seems to be right! Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs. That’s why this headline called it the “Weirdest bull market”Graham is hosting a “tell all” workshop about his Apex Indicator here03/22/2024$4.14$4.03-2.66%$4.30$3.7124,347 shs$4.72 million03/21/2024$4.39$4.14-5.69%$4.69$4.0027,130 shs$4.84 million03/20/2024$4.18$4.39+5.02%$4.82$4.0981,090 shs$5.14 million03/19/2024$3.73$4.18+12.06%$4.30$3.4972,624 shs$4.89 million03/18/2024$4.17$3.73-10.53%$3.96$3.534,278 shs$4.37 million03/15/2024$3.87$4.17+7.75%$4.20$3.4015,644 shs$4.88 million03/14/2024$3.50$3.87+10.57%$3.89$3.3447,197 shs$4.53 million03/13/2024$4.02$3.50-12.94%$3.94$3.4820,807 shs$4.10 million03/12/2024$4.95$4.02-18.79%$4.86$3.78100,795 shs$4.70 million03/11/2024$4.53$4.95+9.27%$5.48$4.52539,398 shs$5.79 million03/08/2024$4.23$4.53+7.09%$4.78$4.3031,192 shs$5.30 million03/07/2024$3.98$4.23+6.28%$4.52$4.0013,756 shs$4.95 million03/06/2024$4.25$3.98-6.35%$4.46$3.8536,612 shs$4.66 million03/05/2024$3.66$4.25+16.12%$4.34$3.7123,702 shs$4.97 million03/04/2024$3.51$3.66+4.27%$3.79$3.5210,027 shs$4.29 million03/01/2024$3.05$3.50+14.68%$3.71$2.6439,582 shs$40.99 million02/29/2024$3.10$3.05-1.58%$3.15$3.055,226 shs$3.58 million02/28/2024$2.90$3.10+6.82%$3.22$2.8010,825 shs$3.63 million02/27/2024$3.40$2.90-14.62%$3.12$2.8914,605 shs$3.40 million02/26/2024$3.38$3.40+0.59%$3.49$3.358,678 shs$3.98 million02/23/2024$3.15$3.30+4.77%$3.38$3.163,349 shs$3.86 million02/22/2024$3.00$3.15+4.83%$3.16$2.8011,857 shs$3.68 million02/21/2024$2.70$3.00+11.11%$3.30$2.7024,156 shs$3.51 million02/20/2024$3.31$2.70-18.43%$3.50$2.7013,449 shs$3.16 million02/19/2024$3.31$3.31$3.62$3.108,570 shs$3.88 million Related Companies: AGRX Stock Price Chart BPTSY Stock Price Chart MBIO Stock Price Chart SXTP Stock Price Chart ONCO Stock Price Chart BPTS Stock Price Chart CWBR Stock Price Chart NTBL Stock Price Chart ARAV Stock Price Chart SNOA Stock Price Chart Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRPX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.